Biosimilar Monoclonal Antibodies Market - Global Outlook and Forecast 2022-2028

Biosimilar Monoclonal Antibodies Market - Global Outlook and Forecast 2022-2028

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Biosimilar Monoclonal Antibodies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biosimilar Monoclonal Antibodies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biosimilar Monoclonal Antibodies Overall Market Size
2.1 Global Biosimilar Monoclonal Antibodies Market Size: 2021 VS 2028
2.2 Global Biosimilar Monoclonal Antibodies Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Biosimilar Monoclonal Antibodies Sales: 2017-2028
3 Company Landscape
3.1 Top Biosimilar Monoclonal Antibodies Players in Global Market
3.2 Top Global Biosimilar Monoclonal Antibodies Companies Ranked by Revenue
3.3 Global Biosimilar Monoclonal Antibodies Revenue by Companies
3.4 Global Biosimilar Monoclonal Antibodies Sales by Companies
3.5 Global Biosimilar Monoclonal Antibodies Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Biosimilar Monoclonal Antibodies Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Biosimilar Monoclonal Antibodies Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biosimilar Monoclonal Antibodies Players in Global Market
3.8.1 List of Global Tier 1 Biosimilar Monoclonal Antibodies Companies
3.8.2 List of Global Tier 2 and Tier 3 Biosimilar Monoclonal Antibodies Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Biosimilar Monoclonal Antibodies Market Size Markets, 2021 & 2028
4.1.2 Infliximab
4.1.3 Rituximab
4.1.4 Trastuzumab
4.1.5 Adalimumab
4.1.6 Other
4.2 By Type - Global Biosimilar Monoclonal Antibodies Revenue & Forecasts
4.2.1 By Type - Global Biosimilar Monoclonal Antibodies Revenue, 2017-2022
4.2.2 By Type - Global Biosimilar Monoclonal Antibodies Revenue, 2023-2028
4.2.3 By Type - Global Biosimilar Monoclonal Antibodies Revenue Market Share, 2017-2028
4.3 By Type - Global Biosimilar Monoclonal Antibodies Sales & Forecasts
4.3.1 By Type - Global Biosimilar Monoclonal Antibodies Sales, 2017-2022
4.3.2 By Type - Global Biosimilar Monoclonal Antibodies Sales, 2023-2028
4.3.3 By Type - Global Biosimilar Monoclonal Antibodies Sales Market Share, 2017-2028
4.4 By Type - Global Biosimilar Monoclonal Antibodies Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Biosimilar Monoclonal Antibodies Market Size, 2021 & 2028
5.1.2 Oncology
5.1.3 Autoimmune Disease
5.1.4 Other
5.2 By Application - Global Biosimilar Monoclonal Antibodies Revenue & Forecasts
5.2.1 By Application - Global Biosimilar Monoclonal Antibodies Revenue, 2017-2022
5.2.2 By Application - Global Biosimilar Monoclonal Antibodies Revenue, 2023-2028
5.2.3 By Application - Global Biosimilar Monoclonal Antibodies Revenue Market Share, 2017-2028
5.3 By Application - Global Biosimilar Monoclonal Antibodies Sales & Forecasts
5.3.1 By Application - Global Biosimilar Monoclonal Antibodies Sales, 2017-2022
5.3.2 By Application - Global Biosimilar Monoclonal Antibodies Sales, 2023-2028
5.3.3 By Application - Global Biosimilar Monoclonal Antibodies Sales Market Share, 2017-2028
5.4 By Application - Global Biosimilar Monoclonal Antibodies Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Biosimilar Monoclonal Antibodies Market Size, 2021 & 2028
6.2 By Region - Global Biosimilar Monoclonal Antibodies Revenue & Forecasts
6.2.1 By Region - Global Biosimilar Monoclonal Antibodies Revenue, 2017-2022
6.2.2 By Region - Global Biosimilar Monoclonal Antibodies Revenue, 2023-2028
6.2.3 By Region - Global Biosimilar Monoclonal Antibodies Revenue Market Share, 2017-2028
6.3 By Region - Global Biosimilar Monoclonal Antibodies Sales & Forecasts
6.3.1 By Region - Global Biosimilar Monoclonal Antibodies Sales, 2017-2022
6.3.2 By Region - Global Biosimilar Monoclonal Antibodies Sales, 2023-2028
6.3.3 By Region - Global Biosimilar Monoclonal Antibodies Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Biosimilar Monoclonal Antibodies Revenue, 2017-2028
6.4.2 By Country - North America Biosimilar Monoclonal Antibodies Sales, 2017-2028
6.4.3 US Biosimilar Monoclonal Antibodies Market Size, 2017-2028
6.4.4 Canada Biosimilar Monoclonal Antibodies Market Size, 2017-2028
6.4.5 Mexico Biosimilar Monoclonal Antibodies Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Biosimilar Monoclonal Antibodies Revenue, 2017-2028
6.5.2 By Country - Europe Biosimilar Monoclonal Antibodies Sales, 2017-2028
6.5.3 Germany Biosimilar Monoclonal Antibodies Market Size, 2017-2028
6.5.4 France Biosimilar Monoclonal Antibodies Market Size, 2017-2028
6.5.5 U.K. Biosimilar Monoclonal Antibodies Market Size, 2017-2028
6.5.6 Italy Biosimilar Monoclonal Antibodies Market Size, 2017-2028
6.5.7 Russia Biosimilar Monoclonal Antibodies Market Size, 2017-2028
6.5.8 Nordic Countries Biosimilar Monoclonal Antibodies Market Size, 2017-2028
6.5.9 Benelux Biosimilar Monoclonal Antibodies Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Biosimilar Monoclonal Antibodies Revenue, 2017-2028
6.6.2 By Region - Asia Biosimilar Monoclonal Antibodies Sales, 2017-2028
6.6.3 China Biosimilar Monoclonal Antibodies Market Size, 2017-2028
6.6.4 Japan Biosimilar Monoclonal Antibodies Market Size, 2017-2028
6.6.5 South Korea Biosimilar Monoclonal Antibodies Market Size, 2017-2028
6.6.6 Southeast Asia Biosimilar Monoclonal Antibodies Market Size, 2017-2028
6.6.7 India Biosimilar Monoclonal Antibodies Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Biosimilar Monoclonal Antibodies Revenue, 2017-2028
6.7.2 By Country - South America Biosimilar Monoclonal Antibodies Sales, 2017-2028
6.7.3 Brazil Biosimilar Monoclonal Antibodies Market Size, 2017-2028
6.7.4 Argentina Biosimilar Monoclonal Antibodies Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Biosimilar Monoclonal Antibodies Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Biosimilar Monoclonal Antibodies Sales, 2017-2028
6.8.3 Turkey Biosimilar Monoclonal Antibodies Market Size, 2017-2028
6.8.4 Israel Biosimilar Monoclonal Antibodies Market Size, 2017-2028
6.8.5 Saudi Arabia Biosimilar Monoclonal Antibodies Market Size, 2017-2028
6.8.6 UAE Biosimilar Monoclonal Antibodies Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Celltrion
7.1.1 Celltrion Corporate Summary
7.1.2 Celltrion Business Overview
7.1.3 Celltrion Biosimilar Monoclonal Antibodies Major Product Offerings
7.1.4 Celltrion Biosimilar Monoclonal Antibodies Sales and Revenue in Global (2017-2022)
7.1.5 Celltrion Key News
7.2 Pfizer (Hospira)
7.2.1 Pfizer (Hospira) Corporate Summary
7.2.2 Pfizer (Hospira) Business Overview
7.2.3 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Major Product Offerings
7.2.4 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales and Revenue in Global (2017-2022)
7.2.5 Pfizer (Hospira) Key News
7.3 3SBIO
7.3.1 3SBIO Corporate Summary
7.3.2 3SBIO Business Overview
7.3.3 3SBIO Biosimilar Monoclonal Antibodies Major Product Offerings
7.3.4 3SBIO Biosimilar Monoclonal Antibodies Sales and Revenue in Global (2017-2022)
7.3.5 3SBIO Key News
7.4 Novartis (Sandoz)
7.4.1 Novartis (Sandoz) Corporate Summary
7.4.2 Novartis (Sandoz) Business Overview
7.4.3 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Major Product Offerings
7.4.4 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales and Revenue in Global (2017-2022)
7.4.5 Novartis (Sandoz) Key News
7.5 Dr Reddy's
7.5.1 Dr Reddy's Corporate Summary
7.5.2 Dr Reddy's Business Overview
7.5.3 Dr Reddy's Biosimilar Monoclonal Antibodies Major Product Offerings
7.5.4 Dr Reddy's Biosimilar Monoclonal Antibodies Sales and Revenue in Global (2017-2022)
7.5.5 Dr Reddy's Key News
7.6 Celgen Biopharma
7.6.1 Celgen Biopharma Corporate Summary
7.6.2 Celgen Biopharma Business Overview
7.6.3 Celgen Biopharma Biosimilar Monoclonal Antibodies Major Product Offerings
7.6.4 Celgen Biopharma Biosimilar Monoclonal Antibodies Sales and Revenue in Global (2017-2022)
7.6.5 Celgen Biopharma Key News
7.7 Cadila Healthcare
7.7.1 Cadila Healthcare Corporate Summary
7.7.2 Cadila Healthcare Business Overview
7.7.3 Cadila Healthcare Biosimilar Monoclonal Antibodies Major Product Offerings
7.7.4 Cadila Healthcare Biosimilar Monoclonal Antibodies Sales and Revenue in Global (2017-2022)
7.7.5 Cadila Healthcare Key News
7.8 Hisun Pharma
7.8.1 Hisun Pharma Corporate Summary
7.8.2 Hisun Pharma Business Overview
7.8.3 Hisun Pharma Biosimilar Monoclonal Antibodies Major Product Offerings
7.8.4 Hisun Pharma Biosimilar Monoclonal Antibodies Sales and Revenue in Global (2017-2022)
7.8.5 Hisun Pharma Key News
7.9 Torrent Pharmaceuticals
7.9.1 Torrent Pharmaceuticals Corporate Summary
7.9.2 Torrent Pharmaceuticals Business Overview
7.9.3 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Major Product Offerings
7.9.4 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales and Revenue in Global (2017-2022)
7.9.5 Torrent Pharmaceuticals Key News
8 Global Biosimilar Monoclonal Antibodies Production Capacity, Analysis
8.1 Global Biosimilar Monoclonal Antibodies Production Capacity, 2017-2028
8.2 Biosimilar Monoclonal Antibodies Production Capacity of Key Manufacturers in Global Market
8.3 Global Biosimilar Monoclonal Antibodies Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biosimilar Monoclonal Antibodies Supply Chain Analysis
10.1 Biosimilar Monoclonal Antibodies Industry Value Chain
10.2 Biosimilar Monoclonal Antibodies Upstream Market
10.3 Biosimilar Monoclonal Antibodies Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biosimilar Monoclonal Antibodies Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Biosimilar Monoclonal Antibodies in Global Market
Table 2. Top Biosimilar Monoclonal Antibodies Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Biosimilar Monoclonal Antibodies Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Biosimilar Monoclonal Antibodies Revenue Share by Companies, 2017-2022
Table 5. Global Biosimilar Monoclonal Antibodies Sales by Companies, (K Units), 2017-2022
Table 6. Global Biosimilar Monoclonal Antibodies Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Biosimilar Monoclonal Antibodies Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Biosimilar Monoclonal Antibodies Product Type
Table 9. List of Global Tier 1 Biosimilar Monoclonal Antibodies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biosimilar Monoclonal Antibodies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Biosimilar Monoclonal Antibodies Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Biosimilar Monoclonal Antibodies Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Biosimilar Monoclonal Antibodies Sales (K Units), 2017-2022
Table 15. By Type - Global Biosimilar Monoclonal Antibodies Sales (K Units), 2023-2028
Table 16. By Application - Global Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Biosimilar Monoclonal Antibodies Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Biosimilar Monoclonal Antibodies Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Biosimilar Monoclonal Antibodies Sales (K Units), 2017-2022
Table 20. By Application - Global Biosimilar Monoclonal Antibodies Sales (K Units), 2023-2028
Table 21. By Region - Global Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Biosimilar Monoclonal Antibodies Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Biosimilar Monoclonal Antibodies Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Biosimilar Monoclonal Antibodies Sales (K Units), 2017-2022
Table 25. By Region - Global Biosimilar Monoclonal Antibodies Sales (K Units), 2023-2028
Table 26. By Country - North America Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Biosimilar Monoclonal Antibodies Sales, (K Units), 2017-2022
Table 29. By Country - North America Biosimilar Monoclonal Antibodies Sales, (K Units), 2023-2028
Table 30. By Country - Europe Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Biosimilar Monoclonal Antibodies Sales, (K Units), 2017-2022
Table 33. By Country - Europe Biosimilar Monoclonal Antibodies Sales, (K Units), 2023-2028
Table 34. By Region - Asia Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Biosimilar Monoclonal Antibodies Sales, (K Units), 2017-2022
Table 37. By Region - Asia Biosimilar Monoclonal Antibodies Sales, (K Units), 2023-2028
Table 38. By Country - South America Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Biosimilar Monoclonal Antibodies Sales, (K Units), 2017-2022
Table 41. By Country - South America Biosimilar Monoclonal Antibodies Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Biosimilar Monoclonal Antibodies Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Biosimilar Monoclonal Antibodies Sales, (K Units), 2023-2028
Table 46. Celltrion Corporate Summary
Table 47. Celltrion Biosimilar Monoclonal Antibodies Product Offerings
Table 48. Celltrion Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Pfizer (Hospira) Corporate Summary
Table 50. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Product Offerings
Table 51. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. 3SBIO Corporate Summary
Table 53. 3SBIO Biosimilar Monoclonal Antibodies Product Offerings
Table 54. 3SBIO Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Novartis (Sandoz) Corporate Summary
Table 56. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Product Offerings
Table 57. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Dr Reddy's Corporate Summary
Table 59. Dr Reddy's Biosimilar Monoclonal Antibodies Product Offerings
Table 60. Dr Reddy's Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Celgen Biopharma Corporate Summary
Table 62. Celgen Biopharma Biosimilar Monoclonal Antibodies Product Offerings
Table 63. Celgen Biopharma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Cadila Healthcare Corporate Summary
Table 65. Cadila Healthcare Biosimilar Monoclonal Antibodies Product Offerings
Table 66. Cadila Healthcare Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Hisun Pharma Corporate Summary
Table 68. Hisun Pharma Biosimilar Monoclonal Antibodies Product Offerings
Table 69. Hisun Pharma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Torrent Pharmaceuticals Corporate Summary
Table 71. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Product Offerings
Table 72. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Biosimilar Monoclonal Antibodies Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 74. Global Biosimilar Monoclonal Antibodies Capacity Market Share of Key Manufacturers, 2020-2022
Table 75. Global Biosimilar Monoclonal Antibodies Production by Region, 2017-2022 (K Units)
Table 76. Global Biosimilar Monoclonal Antibodies Production by Region, 2023-2028 (K Units)
Table 77. Biosimilar Monoclonal Antibodies Market Opportunities & Trends in Global Market
Table 78. Biosimilar Monoclonal Antibodies Market Drivers in Global Market
Table 79. Biosimilar Monoclonal Antibodies Market Restraints in Global Market
Table 80. Biosimilar Monoclonal Antibodies Raw Materials
Table 81. Biosimilar Monoclonal Antibodies Raw Materials Suppliers in Global Market
Table 82. Typical Biosimilar Monoclonal Antibodies Downstream
Table 83. Biosimilar Monoclonal Antibodies Downstream Clients in Global Market
Table 84. Biosimilar Monoclonal Antibodies Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Biosimilar Monoclonal Antibodies Segment by Type
Figure 2. Biosimilar Monoclonal Antibodies Segment by Application
Figure 3. Global Biosimilar Monoclonal Antibodies Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Biosimilar Monoclonal Antibodies Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Biosimilar Monoclonal Antibodies Revenue, 2017-2028 (US$, Mn)
Figure 7. Biosimilar Monoclonal Antibodies Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Biosimilar Monoclonal Antibodies Revenue in 2021
Figure 9. By Type - Global Biosimilar Monoclonal Antibodies Sales Market Share, 2017-2028
Figure 10. By Type - Global Biosimilar Monoclonal Antibodies Revenue Market Share, 2017-2028
Figure 11. By Type - Global Biosimilar Monoclonal Antibodies Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Biosimilar Monoclonal Antibodies Sales Market Share, 2017-2028
Figure 13. By Application - Global Biosimilar Monoclonal Antibodies Revenue Market Share, 2017-2028
Figure 14. By Application - Global Biosimilar Monoclonal Antibodies Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Biosimilar Monoclonal Antibodies Sales Market Share, 2017-2028
Figure 16. By Region - Global Biosimilar Monoclonal Antibodies Revenue Market Share, 2017-2028
Figure 17. By Country - North America Biosimilar Monoclonal Antibodies Revenue Market Share, 2017-2028
Figure 18. By Country - North America Biosimilar Monoclonal Antibodies Sales Market Share, 2017-2028
Figure 19. US Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Biosimilar Monoclonal Antibodies Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Biosimilar Monoclonal Antibodies Sales Market Share, 2017-2028
Figure 24. Germany Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
Figure 25. France Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Biosimilar Monoclonal Antibodies Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Biosimilar Monoclonal Antibodies Sales Market Share, 2017-2028
Figure 33. China Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
Figure 37. India Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Biosimilar Monoclonal Antibodies Revenue Market Share, 2017-2028
Figure 39. By Country - South America Biosimilar Monoclonal Antibodies Sales Market Share, 2017-2028
Figure 40. Brazil Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Biosimilar Monoclonal Antibodies Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Biosimilar Monoclonal Antibodies Sales Market Share, 2017-2028
Figure 44. Turkey Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Biosimilar Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
Figure 48. Global Biosimilar Monoclonal Antibodies Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Biosimilar Monoclonal Antibodies by Region, 2020 VS 2027
Figure 50. Biosimilar Monoclonal Antibodies Industry Value Chain
Figure 51. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147

According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......

Global Biosimilar Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147

According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......

Global Biosimilars Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......

Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs